Chinese Medicinal Formula (MHGWT)‎ for Relieving Diabetic Neuropathic Pain : A Randomized, Double-Blind, Placebo-Controlled Trial

Abstract EN

Objective.

To investigate the effects of modified Hungqi Guizhi Wuwu Tang (MHGWT), a formula that comprises Chinese medicinal herbs, in relieving neuropathic pain in diabetics.

Method.

Between March 2008 and April 2009, 112 participants were randomly assigned to either the MHGWT group, whose members received MHGWT (n=56), or the control group, whose members received a placebo (n=56).

Diabetic neuropathic pain (DNP) was rated using the 15-item Short-Form Brief Pain Inventory (SF-BPI), the 17-item Short-Form McGill Pain Questionnaire (SF-MPQ), the 13-item Modified Michigan Neuropathy Screening Instrument (MMNSI), and the 36-item “SF-36.” Nerve conduction studies (NCSs) were performed before and after treatment.

Results.

After 12 weeks of treatment, the SF-MPQ and SF-BPI scores of the MHGWT group were significantly (P<0.05) reduced and a significant difference between the groups was observed (P<0.05).

The levels of NCS in the MHGWT group were nonsignificantly (P>0.05) reduced, and no significant difference in NCS level was observed between the groups (P>0.05).

Conclusions.

MHGWT shows promise in relieving DNP and deserves further investigation.